{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:51:19Z","timestamp":1792086679773,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.parint.2023.102848","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T16:48:27Z","timestamp":1703782107000},"page":"102848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Amphotericin B loaded nanoemulsion: Optimization, characterization and in-vitro activity against L. donovani promastigotes"],"prefix":"10.1016","volume":"100","author":[{"given":"Vikram Mohanlal","family":"Prajapat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Aalhate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitha","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srushti","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrani","family":"Maji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujala","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin Pal","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.parint.2023.102848_bb0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.parint.2023.102848_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00048-18","article-title":"Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives","volume":"31","author":"Alves","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.parint.2023.102848_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect. Dis. Clin."},{"issue":"1","key":"10.1016\/j.parint.2023.102848_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.idc.2018.10.005","article-title":"Visceral leishmaniasis: recent advances in diagnostics and treatment regimens","volume":"33","author":"van Griensven","year":"2019","journal-title":"Infect. Dis. Clin."},{"issue":"10","key":"10.1016\/j.parint.2023.102848_bb0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2217\/nnm-2020-0482","article-title":"Nanotechnology approaches for delivery and targeting of amphotericin B in fungal and parasitic diseases","volume":"16","author":"Jafari","year":"2021","journal-title":"Nanomedicine"},{"issue":"10","key":"10.1016\/j.parint.2023.102848_bb0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00249-014-0983-8","article-title":"Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments","volume":"43","author":"Kami\u0144ski","year":"2014","journal-title":"Eur. Biophys. J."},{"issue":"48","key":"10.1016\/j.parint.2023.102848_bb0035","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1021\/jp510245n","article-title":"Self-association of amphotericin B: spontaneous formation of molecular structures responsible for the toxic side effects of the antibiotic","volume":"118","author":"Starzyk","year":"2014","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.parint.2023.102848_bb0040","article-title":"Amphotericin B: a drug of choice for Visceral Leishmaniasis","volume":"106661","author":"Kumari","year":"2022","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.parint.2023.102848_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.parint.2023.102848_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/ph13060121","article-title":"Copolymeric micelles overcome the oral delivery challenges of amphotericin B","volume":"13","author":"Nimtrakul","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.parint.2023.102848_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-5173(96)04473-0","article-title":"Amphotericin B eye drops as a lipidic emulsion","volume":"137","author":"Cohen","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.parint.2023.102848_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.parint.2023.102848_bb0065","doi-asserted-by":"crossref","first-page":"103566","DOI":"10.1016\/j.jddst.2022.103566","article-title":"Development and characterization of an amphotericin B-loaded nanoemulsion applied to Candida auris biofilms control","volume":"74","author":"Marena","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.parint.2023.102848_bb0070","doi-asserted-by":"crossref","first-page":"1052478","DOI":"10.3389\/fmicb.2022.1052478","article-title":"Leishmaniasis: recent epidemiological studies in the Middle East","volume":"13","author":"Knight","year":"2023","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.parint.2023.102848_bb0075","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/acsbiomaterials.0c01505","article-title":"Enabling Oral Amphotericin B Delivery by Merging the Benefits of Prodrug Approach and Nanocarrier-Mediated Drug Delivery","volume":"9","author":"Thanki","year":"2023","journal-title":"ACS Biomate Sci. & Eng."},{"issue":"1","key":"10.1016\/j.parint.2023.102848_bb0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/mp700081v","article-title":"Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles","volume":"5","author":"Vakil","year":"2008","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.parint.2023.102848_bb0085","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","article-title":"Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone\u00ae","volume":"26","author":"Italia","year":"2009","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.parint.2023.102848_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40005-020-00474-z","article-title":"Development of amphotericin B nanosuspensions for fungal keratitis therapy: effect of self-assembled \u03b3-cyclodextrin","volume":"50","author":"Jansook","year":"2020","journal-title":"J. Pharm. Investig."},{"issue":"1","key":"10.1016\/j.parint.2023.102848_bb0095","first-page":"29","article-title":"Lipid systems for the delivery of amphotericin B in antifungal therapy","volume":"12","author":"Faustino","year":"2020"},{"issue":"14","key":"10.1016\/j.parint.2023.102848_bb0100","first-page":"3596","article-title":"Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non\u2010toxic chemotherapy","volume":"172","author":"Gupta","year":"2015"},{"issue":"8","key":"10.1016\/j.parint.2023.102848_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080699","article-title":"In vitro evaluation of self-nano-emulsifying drug delivery systems (SNEDDS) containing room temperature ionic liquids (RTILs) for the oral delivery of amphotericin B","volume":"12","author":"Kontogiannidou","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.parint.2023.102848_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jddst.2017.04.017","article-title":"Oral amphotericin B: the journey from bench to market","volume":"42","author":"Serrano","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1\u20132","key":"10.1016\/j.parint.2023.102848_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2014.07.004","article-title":"New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp","volume":"473","author":"Ruiz","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.parint.2023.102848_bb0120","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/pharmaceutics14112316","article-title":"Review of novel oral amphotericin B formulations for the treatment of parasitic infections","volume":"14","author":"Wasan","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.parint.2023.102848_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2016.1225852","article-title":"Design of amphotericin B oral formulation for antifungal therapy","volume":"24","author":"Liu","year":"2017","journal-title":"Drug Deliv."},{"issue":"1\u20133","key":"10.1016\/j.parint.2023.102848_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.colsurfa.2004.09.029","article-title":"Nano-emulsion formation by emulsion phase inversion","volume":"251","author":"Fernandez","year":"2004","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"19","key":"10.1016\/j.parint.2023.102848_bb0135","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2217\/nnm-2018-0088","article-title":"Nanoemulsions in drug delivery: formulation to medical application","volume":"13","author":"Tayeb","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.parint.2023.102848_bb0140","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluation","author":"Ateeq","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.parint.2023.102848_bb0145","first-page":"539","article-title":"Strategies for the design of orally bioavailable antileishmanial treatments","volume":"454","author":"Pham","year":"2013"},{"issue":"1","key":"10.1016\/j.parint.2023.102848_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2013.04.020","article-title":"Oral delivery of anticancer drugs: challenges and opportunities","volume":"170","author":"Thanki","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.parint.2023.102848_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2017.01.014","article-title":"BCS class IV drugs: highly notorious candidates for formulation development","volume":"248","author":"Ghadi","year":"2017","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.parint.2023.102848_bb0160","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/jps.21179","article-title":"Amphotericin B formulations and drug targeting","volume":"97","author":"Torrado","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.parint.2023.102848_bb0165","series-title":"Enabling Oral Amphotericin B Delivery by Merging the Benefits of Prodrug Approach and Nanocarrier-Mediated Drug Delivery","author":"Thanki","year":"2021"},{"key":"10.1016\/j.parint.2023.102848_bb0170","first-page":"125","article-title":"Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis","volume":"70","author":"Caldeira","year":"2015"},{"issue":"3","key":"10.1016\/j.parint.2023.102848_bb0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/10837450.2013.860551","article-title":"Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil","volume":"20","author":"Alanazi","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.parint.2023.102848_bb0180","first-page":"62","article-title":"Th-1 biased immunomodulation and synergistic antileishmanial activity of stable cationic lipid\u2013polymer hybrid nanoparticle: biodistribution and toxicity assessment of encapsulated amphotericin B","volume":"89","author":"Asthana","year":"2015"},{"issue":"4","key":"10.1016\/j.parint.2023.102848_bb0185","first-page":"357","article-title":"A new nanoemulsion formulation improves antileishmanial activity and reduces toxicity of amphotericin B","volume":"26","author":"Santos","year":"2018"},{"key":"10.1016\/j.parint.2023.102848_bb0190","article-title":"An update on sophisticated and advanced analytical tools for surface characterization of nanoparticles","volume":"33","author":"Patil","year":"2022","journal-title":"Surf. Interfaces"},{"key":"10.1016\/j.parint.2023.102848_bb0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jddst.2018.10.003","article-title":"Nanostructured lipid carriers containing amphotericin B: development, in vitro release assay, and storage stability","volume":"48","author":"Santiago","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.parint.2023.102848_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113631","article-title":"Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer","volume":"233","author":"Saren","year":"2024","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.parint.2023.102848_bb0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.phymed.2018.04.030","article-title":"Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity","volume":"47","author":"Koutsoni","year":"2018","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.parint.2023.102848_bb0210","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/10837450.2023.2206668","article-title":"Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy","volume":"28","author":"Dhuri","year":"2023","journal-title":"Pharm. Dev. Technol."},{"issue":"4","key":"10.1016\/j.parint.2023.102848_bb0215","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1128\/AAC.01984-12","article-title":"Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules","volume":"57","author":"Asthana","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2023.102848_bb0220","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jconrel.2022.05.034","article-title":"Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer","volume":"348","author":"Gupta","year":"2022","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.parint.2023.102848_bb0225","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s13346-023-01299-7","article-title":"Nanomedicine in therapeutic warfront against estrogen receptor\u2013positive breast cancer","volume":"13","author":"Aalhate","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.parint.2023.102848_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpharm.2019.03.010","article-title":"Cytotoxicity and permeability enhancement of Capmul\u00ae MCM in nanoemulsion formulation","volume":"561","author":"Bunchongprasert","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.parint.2023.102848_bb0235","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.colsurfb.2009.11.021","article-title":"Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe","volume":"76","author":"Bali","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"11","key":"10.1016\/j.parint.2023.102848_bb0240","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1039\/C5SM02958A","article-title":"Nanoemulsions: formation, properties and applications","volume":"12","author":"Gupta","year":"2016","journal-title":"Soft Matter"},{"key":"10.1016\/j.parint.2023.102848_bb0245","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.parint.2023.102848_bb0250","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0021-9797(70)90158-X","article-title":"The stability of W\/O type emulsions as a function of temperature and of the hydrophilic chain length of the emulsifier","volume":"32","author":"Saito","year":"1970","journal-title":"J. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.parint.2023.102848_bb0255","first-page":"111","article-title":"Factors affecting drug release from liposomes","volume":"13","author":"Lindner","year":"2010","journal-title":"Curr. Opin. Drug Discov. Dev."},{"issue":"11","key":"10.1016\/j.parint.2023.102848_bb0260","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.febslet.2006.04.021","article-title":"Binding of antibiotic amphotericin B to lipid membranes: a 1H NMR study","volume":"580","author":"Gabrielska","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.parint.2023.102848_bb0265","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s13346-020-00821-5","article-title":"Development, characterization, and anti-leishmanial activity of topical amphotericin B nanoemulsions","volume":"10","author":"dos Santos Matos","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.parint.2023.102848_bb0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2022.05.002","article-title":"Nanomedicine as a magic bullet for combating lymphoma","volume":"347","author":"Mahajan","year":"2022","journal-title":"J. Control. Release"}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576923001265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576923001265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T09:40:56Z","timestamp":1717321256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576923001265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":54,"alternative-id":["S1383576923001265"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2023.102848","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amphotericin B loaded nanoemulsion: Optimization, characterization and in-vitro activity against L. donovani promastigotes","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2023.102848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102848"}}